Category Archives: US pressure on India

#ModiMeetsTrump: Peter Maybarduk Exclusive

Director of Access To Medicines Peter Maybarduk believes big pharma co’s money is driving US policies and US may pressurise India on drug prices Advertisements

Posted in Uncategorized, US pressure on India | Leave a comment

Plea to Modi on affordable drugs

Source: The Hindu BusinessLine | June 23, 2017: PATENT INJUSTICE Plea to Modi on affordable drugs Ahead of US President Donald Trump and Prime Minister Narendra Modi’s meeting at the White House, Doctors Without Borders/Médecins Sans Frontières (MSF) has cautioned that US … Continue reading

Posted in Uncategorized, US pressure on India | Leave a comment

Activists warn of US pressure to change drug regulatory system

Source: DNA | June 26, 2017 In the past, the US government has successfully pressurised India to change its pro-public health stance, and there may be renewed demands for more concessions As US President Donald Trump and Indian Prime Minister … Continue reading

Posted in Uncategorized, US pressure on India | Leave a comment

MSF urges Modi to withstand US pressure to change India’s IP laws

  By Joe C Mathew, Business Today | June 23, 2017 Medicines Sans Frontiers (MSF) has urged India to withstand U.S. pressure to change its drug regulatory and patent system as it could result in millions of people in the U.S. … Continue reading

Posted in Uncategorized, US pressure on India | Leave a comment

TRIPS Council Members: Defining IP Rights And The Public Interest

Source: IP Watch 15/06/2017 BY CATHERINE SAEZ, INTELLECTUAL PROPERTY WATCH “Political and economic pressure placed on governments to forgo the use of TRIPS flexibilities violates the integrity and legitimacy of the system of legal duties and rights created by the … Continue reading

Posted in Compulsory Licensing, Doha Declaration, HIV/Aids, TRIPS, US pressure on India | Leave a comment

Indian pharma industry fears tougher US stance on IP

Prices of patented drugs are lower in Canada, United Kingdom and Australia in comparison to the US By Aneesh Phadnis & Reuters| Published: Business Standard | february 1, 2017 Indian pharma industry is fearing a tougher US government stance on intellectual … Continue reading

Posted in Generics, IPR, Uncategorized, US pressure on India | Leave a comment

Compulsory licensing: India gave ‘private reassurance’, says US business council

In a review submitted to USTR, four US industry bodies have said that India has developed a “positive” approach over the compulsory licensing issue.  Written by Liz Mathew, The Indian Express | New Delhi | March 8, 2016 The US-India … Continue reading

Posted in Compulsory Licensing, Special 301 report, Uncategorized, US pressure on India | Leave a comment